News

Investor News from Reuters

December 10, 2012 - REUTERS

DELCATH TO PRESENT AT OPPENHEIMER HEALTHCARE CONFERENCE ON DECEMBER 13

December 05, 2012 - REUTERS

DELCATH PROVIDES UPDATE ON NDA SUBMISSION FOR ITS CHEMOSATURATION SYSTEM

December 05, 2012 - REUTERS

DELCATH SECURES A $35 MILLION COMMITTED EQUITY FINANCING FACILITY WITH TERRAPIN OPPORTUNITY, L.P.

December 04, 2012 - REUTERS

DELCATH ANNOUNCES WEBINAR TO DISCUSS RECENT CORPORATE DEVELOPMENTS

November 07, 2012 - REUTERS

DELCATH REPORTS THIRD QUARTER 2012 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS

November 06, 2012 - REUTERS

DELCATH TO PRESENT AT LAZARD CAPITAL MARKETS HEALTHCARE CONFERENCE ON NOVEMBER 13

November 05, 2012 - REUTERS

DELCATH RECEIVES REGULATORY APPROVAL FOR THE GENERATION TWO HEPATIC CHEMOSAT® DELIVERY SYSTEM IN AUSTRALIA

November 01, 2012 - REUTERS

DELCATH ANNOUNCES JUNE 15, 2013 PDUFA GOAL DATE FOR NEW DRUG APPLICATION

October 26, 2012 - REUTERS

DELCATH TO CONDUCT THIRD QUARTER 2012 RESULTS CONFERENCE CALL

October 22, 2012 - REUTERS

DELCATH ANNOUNCES CE MARKING FOR HEPATIC CHEMOSAT® DELIVERY SYSTEM FOR USE WITH DOXORUBICIN INJECTION

October 15, 2012 - REUTERS

DELCATH ANNOUNCES FDA ACCEPTS NEW DRUG APPLICATION FOR ITS PROPRIETARY CHEMOSATURATION SYSTEM WITH MELPHALAN HYDROCHLORIDE

September 24, 2012 - REUTERS

DELCATH HOSTS EXPERT SYMPOSIUM AT EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ANNUAL CONGRESS

September 19, 2012 - REUTERS

EXPERT SYMPOSIUM AT CIRSE ANNUAL CONGRESS DISCUSSES ADVANTAGES OF USING DELCATH CHEMOSAT SYSTEM TO TREAT CANCERS IN THE LIVER

September 10, 2012 - REUTERS

DELCATH TO HOST EXPERT SYMPOSIUM AT CIRSE ANNUAL CONGRESS

September 04, 2012 - REUTERS

DELCATH EXPANDS EUROPEAN PRODUCT WEBSITE FOR CHEMOSAT

August 15, 2012 - REUTERS

Delcath Submits New Drug Application For Proprietary Chemosaturation System To The U.S. Food And Drug Administration

August 08, 2012 - REUTERS

Delcath To Present At Upcoming Investor Conferences

August 07, 2012 - REUTERS

Delcath Reports Second Quarter 2012 Financial Results And Highlights Recent Accomplishments

July 17, 2012 - REUTERS

Delcath To Conduct Second Quarter 2012 Results Conference Call

July 09, 2012 - REUTERS

Delcath To Present At JMP Securities Healthcare Conference On July 12

July 09, 2012 - REUTERS

Delcath Announced Changes To Board Of Directors

June 18, 2012 - REUTERS

Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program

June 05, 2012 - REUTERS

Post-Hoc Analysis Of Delcath's Phase 3 Trial Presented At ASCO

May 31, 2012 - REUTERS

Delcath Announces Exercise of Underwriters' Over-Allotment Option and Closing of $23 Million Public Offering of Common Stock and Warrants

May 30, 2012 - REUTERS

Delcath To Host Analyst Meeeting

May 25, 2012 - REUTERS

Delcath Prices $20 Million Public Offering of Common Stock and Warrants

May 24, 2012 - REUTERS

Delcath Announces Proposed Public Offering Of Common Stock And Warrants

May 21, 2012 - REUTERS

Delcath to Webcast Management's Presentation at Annual Meeting of Stockholders

May 08, 2012 - REUTERS

Delcath Highlights First Quarter 2012 And Recent Accomplishments

May 01, 2012 - REUTERS

Delcath To Report Fiscal 2012 First Quarter Results And Conduct Conference Call

April 26, 2012 - REUTERS

Low Side Effects Seen in Treatment With Delcath's Second Generation Hemofiltration Cartridge

April 23, 2012 - REUTERS

Delcath Systems, Inc. Secures $20 Million Credit Facility

April 13, 2012 - REUTERS

Delcath Announces First Patient Treatment Using Second Generation Hemofiltration Cartridge

April 10, 2012 - REUTERS

Delcath Announces Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital for Training and Launch of Hepatic Chemosat Delivery System

April 05, 2012 - REUTERS

Delcath Receives European Regulatory Approval for Second Generation Hemofiltration Cartridge

March 27, 2012 - REUTERS

Delcath Announces Agreement With Istituto Nazionale Tumori Fondazione G. Pascale for Further Expansion of CHEMOSAT in Italy

March 26, 2012 - REUTERS

Delcath Expands Global Marketing Team With Key Pharma Oncology Hire

March 20, 2012 - REUTERS

Delcath Announces First Commercial CHEMOSAT Order in Europe

March 19, 2012 - REUTERS

Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain

March 15, 2012 - REUTERS

Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France

March 09, 2012 - REUTERS

Delcath Selects Quintiles to Support EU Launch of CHEMOSAT

March 08, 2012 - REUTERS

Delcath Highlights Fiscal 2011 Fourth Quarter and Full Year Results and Recent Developments

March 02, 2012 - REUTERS

Delcath to Conduct Conference Call to Discuss Full Year 2011 Results and Recent Corporate Progress

February 28, 2012 - REUTERS

Delcath to Present at 24th Annual Roth Growth Stock Conference on March 12

February 27, 2012 - REUTERS

Delcath Announces First CHEMOSAT Procedures in Germany

February 16, 2012 - REUTERS

Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System

February 15, 2012 - REUTERS

Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology

February 14, 2012 - REUTERS

Delcath Receives Regulatory Approval to Commercialize Hepatic CHEMOSAT® Delivery System in Australia

February 13, 2012 - REUTERS

Delcath Appoints Industry Veteran Chris Houchins as Senior Vice President of Clinical and Medical Affairs

February 09, 2012 - REUTERS

Delcath to Present at the 14th Annual BIO CEO & Investor Conference on February 14

February 02, 2012 - REUTERS

Delcath Announces First European Chemosat Procedures